Glaxosmithkline Pharmaceuticals Ltd

BSE Code : 500660
NSE Symbol : GLAXO
ISIN : INE159A01016
Industry :PHARMACEUTICALS - MULTINATIONAL

Trade Now

Get Quotes

2,936.50 -226.10(-7.15%)

Open Price (₹)

3,162.90

Prev. Close (₹)

3,162.60

Volume (No’s)

282,736

Market Cap (₹)

49,746.08

Low Price (₹)

2,890.00

High Price (₹)

3,184.30

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
01-Aug-2025	NA	As per attachment We wish to inform you that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company's shares is closed from Tuesday, 1st July 2025 and shall reopen on Wednesday, 6th August 2025 i.e. after the approval & declaration of Un-Audited financial results for first quarter ended 30th June 2025 by the Board of Directors at its meeting scheduled to be held on Friday, 1st August 2025. Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve Board Meeting Intimation (As Per BSE Announcement Dated on :04.07.2025) As per attachment (As Per BSE Announcement Dated on: 01.08.2025)
27-Jun-2025	NA	The Board of Directors has fixed Friday, 27 th June 2025 as the date of the 100th Annual General Meeting ('AGM') of the Company through Vic;leo Conferencing / Other Audio Visual Means in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India. 100Th Annual General Meeting on 27th June 2025 Outcome of AGM (As Per BSE Announcement Dated on: 27.06.2025)
30-May-2025	NA	The Company has fixed Friday, 30th May 2025, as the Record Date for determining entitlement of members to final dividend for the financial year ended 31st March,2025. If the final dividend as recommended by the Board of Directors is approved at the AGM , payment of such dividend, subject to deduction of tax at source, will be made on and after Monday, 30th June 2025 as under
30-May-2025	NA	420% Final Dividend
18-May-2025	NA	5. Re-Appointment of Dr. (Ms.) Sunita Maheshwari, as an Independent Director Pursuant to Regulation 30 and Schedule Ill (A) (7) of the Listing and Disclosure Requirements Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today re-appointed Dr. (Ms.) Sunita Maheshwari as Independent Director of the Company with effect from today i.e. 18th May 2025, for a period of second term of three (3) consecutive years, not liable to retire by rotation, subject to the approval of Shareholders.